Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Machine learning, GWAS divide and conquer PCOS

July 2, 2020

Placental attachment theory

July 2, 2020

FDA approves Dojolvi for long-chain fatty acid oxidation disorders

July 1, 2020

Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group disclose S1P1 agonists

July 1, 2020

Preclinical studies show promise of GLP-1R agonist GL-0034 for treating diabetes

July 1, 2020

First phase I data presented for HM-15136

June 30, 2020

Japanese approval of Rybelsus for type 2 diabetes

June 29, 2020

FDA approves Mycapssa for long-term maintenance treatment in patients with acromegaly

June 29, 2020

First-in-human data presented for YG-1699

June 29, 2020

First patient dosed in phase I study of IMT-002

June 26, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...